Tumor Treatment Fields (TTFields) is the first FDA approved treatment modality in nearly 10 years for patients with newly diagnosed glioblastoma multiforme (GBM). Sign up for this interactive webinar presented by Jennifer Connelly, MD, from the Department of Neurology at the Medical College of Wisconsin. Dr. Connelly will take a comprehensive look into the role of TTFields in the treatment of GBMs. She will discuss how the device is thought to effect tumor cells as well as review the application of the device and management of the most common side-effects.
This webinar includes an interactive Q&A session with Dr. Connelly.